FDA Investigator H Ljamilla Selby

H Ljamilla Selby has conducted inspections on 22 sites in 2 countries as of 03 Apr 2017. See below for a list of the FDA enforcement documents resulting from those inspections.

Investigator Details

Number of Inspected Sites:
22
Last Inspection Date:
03 Apr 2017
Investigator Role:
FDA Investigation Participant
Redica ID:
100008172
Countries of Inspections:
United States of America, India
FDA Investigators that have inspected at least one site in common with H Ljamilla Selby:
Anastasia I Onuorah, Anastasia M Shields, Anh M Lac, Anita R Michael, Anthony A Charity, Audrey Thereset Uy, Brian J Ryan, Carlos Chavez, Casey L Hamblin, Charles D Brown, Christopher D Rush, Connie L Hannon Rabel, Craig D Zagata, Cynthia A Harris, MD, RN, Daniel J Lahar, Danny D Horner, Darla J Christopher, David A Oluwo, David M Beltran, Debra J Bennett, Doan T Nguyen, PharmD, Dr. Jason R Caballero, Edward D Mcdonald, Elizabeth D Connell, Elmina E Akwo, Elmina E Mboh, Farhana Khan, Frank W Perrella, George Pyramides, Habacuc V Barrera, Hala L Selby, Hala Lj Whetstone, Heriberto Negron Rivera, Hung V Le, Iris C Macinnes, James M Mason, James P Mcevoy, Janet B Abt, Javier E Santos, Jd Young, Jeen S Min, Jeffrey D Meng, Jeffrey R Wooley, Jennifer L Huntington, Jenny Agila Sefen, Jeremy W Rotton, Jodi M Gatica, Joel D Martinez, John T Chapman, Joseph L Despins, PhD, Julianne C Mccullough, Karen C Daugherty, Karthik B Iyer, Karyn M Campbell, Kendra L Brooks, Kristina J Donohue, Kristina L Conroy, Kristina Mjoyce Pittman, L Grant, Lauren E Skokan, LCDR Susan E Polifko, Leighton Kn Gai, Linda M Hoover, Lisa M Puttonen, Lisa R Whitt, Lloyd D Payne, Lucas B Leake, Maotang Zhou, PhD, Marc R Dickens, Margaret M Annes, Mary Davis Lopez, Massoud Motamed, Matthew R Maddox, Matthew R Noonan, Michael A Taylor, Michael Gurbarg, Michael J Nerz, Michael R Goga, Michelle A Krayer, Muralidhara B Gavini, PhD, Nije A Thomas, Nikhil Thakur, Norman K Starks, Olalere D Fasipe, Patrice S Hall, Patty P Kaewussdangkul, Philip M Steele, PhD, Phillip D Waldron, Qing Delgado, Raffi B Papazian, Ralph H Vocque, Rebecca Co Bryan, Rebecca Rodriguez, Rhonda L Dash, Robin P Mathew, Ronda Rloyd Jones, Rose Ljean Mary, Roy Baby, Saijal P Naik, Sam Pepe, Scott R Nichols, PhD, Scott T Ballard, Sean C Johnson, Sha'tina R Alridge, Shanna N Purdy, Sharon K Thoma, PharmD, Shawn E Larson, Sherrie L Krolczyk, Stephen C Smith, Stephen D Brown, Stephen L Beekman, Susan F Laska, MS, Temar Q Williams, Theresa Kirkham (NMI), Thomas E Friel, Thomas J Arista, Torrance J Slayton, Travis M Beard, Tricia S Martinez, Trina K Vick, Vlada Matusovsky, Yasamin Ameri, Yaw O Osei, Yumi J Hiramine, Yvonne C Mcknight, Yvonne C Wood

H Ljamilla Selby's Documents

Publish Date Document Type Title
March, 2012 FDA 483 Pharma Nobis, LLC - Form 483, 2012-03-16
May, 2013 EIR Alcon Research, LLC - EIR, 2013-05-08
May, 2013 FDA 483 Alcon Research, LLC - Form 483, 2013-05-08
May, 2012 FDA 483 Capellon Pharmaceuticals, LLC - Form 483, 2012-05-10
January, 2012 FDA 483 MEDISCA Inc. - Form 483, 2012-01-26
September, 2013 FDA 483 Specialty Compounding, LLC - Form 483, 2013-09-13
November, 2012 FDA 483 American Aesthetics Medical Supply, Inc. - Form 483, 2012-11-13
January, 2017 FDA 483 AstraZeneca Pharmaceuticals LP - Form 483, 2017-01-30
January, 2013 FDA 483 Global Packaging Systems - Form 483, 2013-01-15
May, 2016 FDA 483 Alcon Research, LLC - Form 483, 2016-05-23
October, 2011 FDA 483 iCAD, Inc. (formerly VuCOMP, Inc.) - Form 483, 2011-10-13
January, 2017 FDA 483 Response AstraZeneca Pharmaceuticals LP - Form 483R, 2017-02-10
June, 2011 FDA 483 Johnson & Johnson Consumer Inc. - Form 483, 2011-06-22
February, 2011 FDA 483 Auditdata, LLC - Form 483, 2011-02-24
August, 2011 EIR OraWell USA - EIR, 2011-08-05
April, 2017 FDA 483 Neuland Laboratories Limited - Form 483, 2017-04-07
December, 2012 FDA 483 Seecor, Inc - Form 483, 2012-12-21
April, 2013 FDA 483 Downing Labs, LLC - Form 483, 2013-04-17
March, 2011 FDA 483 Lannett Company, Inc. - Form 483, 2011-03-21
May, 2016 FDA 483 SOFIE Co. dba SOFIE - Form 483, 2016-05-27
December, 2016 FDA 483 Ajinomoto Bio-Pharma Services India Private Limited - Form 483, 2016-12-09
April, 2011 FDA 483 Accupac, LLC - Form 483, 2011-06-03
March, 2012 EIR Pharma Nobis, LLC - EIR, 2012-03-16
February, 2011 FDA 483 Amoroso Baking Co Inc - Form 483, 2011-02-04
April, 2013 FDA 483 Apothecure, Inc - Form 483, 2013-04-17

Experience Redica Systems’ NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more